Asymmetric Total Synthesis of Nannocystin A
- 18 August 2017
- journal article
- research article
- Published by American Chemical Society (ACS) in The Journal of Organic Chemistry
- Vol. 82 (17) , 9217-9222
Abstract
Nannocystin A is a novel 21-membered macrolactone isolated from myxobacterium Nanocystis sp. It is a potent elongation factor 1 inhibitor and inhibits cancer cell line growth at nanomolar concentrations. In this work, a concise asymmetric total synthesis of nannocystin A has been developed, which features Sharpless epoxidation, Stille coupling, and final macrolactamization.Keywords
Funding Information
- National Natural Science Foundation of China (21372267, 21572027)
This publication has 33 references indexed in Scilit:
- Total synthesis of nannocystin AxChemical Communications, 2017
- Total Synthesis of Nannocystin AOrganic Letters, 2016
- Concise Total Synthesis of Nannocystin AAngewandte Chemie International Edition, 2016
- Asymmetric Total Syntheses of Aetheramides and Their Stereoisomers: Stereochemical Assignment of AetheramidesOrganic Letters, 2016
- Total Syntheses of Nannocystins A and A0, Two Elongation Factor 1 InhibitorsOrganic Letters, 2016
- Total synthesis of calothrixins and their analogues via formal [3+2] cycloaddition of arynes and 2-aminophenanthridinedioneTetrahedron Letters, 2016
- Natural Products as Sources of New Drugs from 1981 to 2014Journal of Natural Products, 2016
- Nannocystin A: an Elongation Factor 1 Inhibitor from Myxobacteria with Differential Anti‐Cancer PropertiesAngewandte Chemie International Edition, 2015
- Discovery, Structure Elucidation, and Biological Characterization of Nannocystin A, a Macrocyclic Myxobacterial Metabolite with Potent Antiproliferative PropertiesAngewandte Chemie International Edition, 2015
- The endeavor of total synthesis and its impact on chemistry, biology and medicineNational Science Review, 2014